Back to search results

Exploring Engagement in Bladder Cancer Clinical Research

This study is for people with bladder cancer who are planning to join a separate clinical trial that tests a specific medical treatment. This study will observe and track how many patients join and complete that other clinical trial, and how many leave early. It aims to understand why people stay or leave clinical research. You can join if you are 18 or older, have bladder cancer, and plan to enroll in a clinical trial. By participating, you can help researchers understand how to improve future clinical trials for bladder cancer patients.

Study design
This is an observational study, meaning it will watch and collect information without giving any specific medical intervention. It plans to include about 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track participation for up to 12 months, measuring how many patients remain in clinical research until completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06009510

Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer

Not Yet Recruiting
Not specifiedAges 18+Observational
Power Life Sciences Inc.
~500 participants
Updated 2023-08-24 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients who decide to participate in a bladder cancer clinical research
Measured over 3 months
+1 more outcome measured

Conditions

Bladder Cancer

Explore related trials

Bladder Carcinoma

NCT06009510

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Power Life Sciences

    San Francisco, Californiastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.

Who to contact

Michael B Gill
[email protected]
4159004227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient has self-identified as planning to enroll in a clinical trial
Patient has been diagnosed with bladder cancer
Patient is a minimum of 18 years or older

Exclusion

Patient does not understand, sign, and return consent form
Inability to perform regular electronic reporting
Patient is pregnant

What this trial measures

  • Number of patients who decide to participate in a bladder cancer clinical research3 months
  • Rate of patients who remain in bladder cancer clinical research to trial completion12 months